Vaccine News and Research

Latest Vaccine News and Research

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Texas Medical Branch, Pfizer Vaccines Research & Development and BioNTech assessed the neutralization titers of sera from individuals vaccinated with the BNT162b2 coronavirus disease 2019 (COVID-19) vaccine and previously infected with the Omicron sublineage BA.1.

10 Jun 2022

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

A recent research letter posted to the JAMA Network Open assessed the durability of immunity conferred by the coronavirus disease 2019 (COVID-19) messenger ribonucleic acid (mRNA)-1273 vaccine.

10 Jun 2022

Study reports robust immunity to SARS-CoV-2 including Omicron BA.1 for all three primary vaccines

In a recent study posted to the medRxiv* pre-print server, researchers in the United Kingdom investigated the effect of two Pfizer/BioNTech BNT162b2 vaccine doses or Oxford/AstraZeneca AZ1222 coronavirus disease 2019 (COVID-19) vaccination and a subsequent BNT162b2 booster dose in a cohort of healthcare workers (HCWs) over six to nine months.

10 Jun 2022

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus compared to fully boosted heart failure patients, according to new research out of Mount Sinai Heart.

9 Jun 2022

KHN’s ‘What the Health?’: Taking a shot at gun control

The House passed a package of bills to restrict the availability of assault weapons to minors and other measures to curb gun violence, but talks in the Senate have yet to produce breakthroughs on what has been a legislative stalemate for years.

9 Jun 2022

New understanding about malaria immunity could lead to the development of effective vaccines

Understanding how people exposed to malaria for the first time develop immunity could lead to creating more effective treatments including vaccines to fight the disease, researchers say.

9 Jun 2022

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

Researchers generated an AI resource to characterize the T cell epitope landscape for SARS-CoV-2 variants of concern.

9 Jun 2022

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

People with certain inflammatory immune conditions affecting the joints, bowel and skin, such as rheumatoid arthritis, may have been more at risk of dying or needing hospital care if they got COVID-19 before vaccination compared with the general population, according to a new study published in The Lancet Rheumatology.

9 Jun 2022

Zoonotic origins of seasonal human coronaviruses

In a recent study posted to the bioRxiv* preprint server, investigators analyzed the evolution and origin of seasonal human coronaviruses (sHCoVs).

8 Jun 2022

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

A molecule in mosquito spit has been identified as a potential new target for vaccination against a range of diseases for which there is no protection or medicine.

8 Jun 2022

Getting fully vaccinated against COVID-19 during pregnancy helps protect young infants

New research offers evidence that getting a second or third dose of the COVID-19 vaccine in the final stages of pregnancy offers protection for infants against SARS-CoV-2 infection (the virus that causes COVID-19 illness).

8 Jun 2022

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Vaccinating household chicken flocks can increase availability and consumption of eggs and meat, leading to better growth of young children in agriculture-dependent families in rural Kenya.

8 Jun 2022

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

Pregnant people who are hospitalized with COVID-19 in Sub-Saharan Africa are dying at a rate far greater than pregnant people without COVID-19 and non-pregnant people with COVID-19, according to a new multicenter study encompassing six African countries.

8 Jun 2022

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

In a recent study, researchers analyzed the incidence of myocarditis among COVID-19 mRNA-1273 vaccinees.

8 Jun 2022

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Researchers assessed the proportion of receptor-binding domain antibodies in COVID-19-recovered patients.

8 Jun 2022

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

In a recent study posted to the medRxiv* pre-print server, researchers from the London School of Hygiene and Tropical Medicine and Hasselt University surveyed the social contact patterns and coronavirus disease 2019 (COVID-19) vaccine uptake among women from 19 European countries pregnant between March 2020 and September 2021.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

In a recent phase III study published in the New England Journal of Medicine, researchers demonstrated that oral molnupiravir was effective in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) therapy among non-vaccinated, non-hospitalized adults at-risk for severe illness.

8 Jun 2022

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

Vaccine News and Research

Latest Vaccine News and Research

Efficacy of BNT162b2 vaccine against SARS-CoV-2 Omicron sublineages and Deltacron

Study finds Moderna COVID vaccine efficacy peaks at 94% after 120 days

Study reports robust immunity to SARS-CoV-2 including Omicron BA.1 for all three primary vaccines

COVID-19 vaccination associated with reduction in hospitalizations and mortality among heart failure patients

KHN’s ‘What the Health?’: Taking a shot at gun control

New understanding about malaria immunity could lead to the development of effective vaccines

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

People with inflammatory immune conditions had increased risk of COVID-19-related death before vaccination

Zoonotic origins of seasonal human coronaviruses

Molecule in mosquito saliva can be a potential new target for halting deadly diseases

Getting fully vaccinated against COVID-19 during pregnancy helps protect young infants

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Pregnant people in Sub-Saharan Africa are at higher risk of complications and death from COVID-19

The cumulative risk of myocarditis/myopericarditis among global mRNA-1273 recipients

Longitudinal kinetics of the serological response in COVID-19 recovered patients over a period of 14 months

Pregnant women's social contacts and COVID vaccination coverage in 19 European countries

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

Molnupiravir reduces hospitalizations and deaths in at-risk, unvaccinated adults with COVID

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in